Overall rank by patents
#3,132
of 49,997 tracked assignees
USPTO PatentsView assignee record - 120 granted patents across 12 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).
The verdict
According to USPTO PatentsView, Guardant ranks #3,132 of 49,997 tracked US assignees by granted-patent volume, with 120 patents across 12 technology areas.
USPTO PatentsView assignee plate
Corpus R3132 · US Corporation #3,132 · 120 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Atombeam Technologies Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Espressif Systems… · near
54 score
Guardant Health · this assignee
54 score
Shenzhen Newsonic · near
54 score
SimpliSafe · near
54 score
Spraying Systems · near
54 score
3D Lighting… · lowest
7 score
What this shows Guardant's Innovation Score is 53.8/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Guardant Health, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 91.7% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2024 (22 grants) versus a trough of 2 in 2018. By volume, Guardant sits between Toshiba Lighting & Technology Corporation and Linak A/S.
From 2019–2021 to 2022–2024, Guardant Health, Inc. moved from 34 to 59 grants (1.74x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #300. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Toshiba Lighting & Technology Corporation
121 patents
Atombeam Technologies Inc.
120 patents
Edwards Japan Limited
120 patents
GRG Banking Equipment Co., Ltd.
120 patents
Guest Tek Interactive Entertainment Ltd.
120 patents
Ixia
120 patents
K-tronics (SUZHOU) Technology Co., Ltd.
120 patents
Linak A/S
120 patents
Guardant Health, Inc.
120 patents
What this shows Guardant holds 120 patents at rank #3,132, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,132 in granted patent volume.
Other assignees with the most granted patents in Guardant's primary technology class.
Two PlainPatent-derived peer sets for Guardant, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (54 here).
Nearest assignees by average claims per patent (22.3 here).
Guardant's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 5 | 4.2% |
| 2018 | 2 | 1.7% |
| 2019 | 4 | 3.3% |
| 2020 | 12 | 10.0% |
| 2021 | 18 | 15.0% |
| 2022 | 16 | 13.3% |
| 2023 | 21 | 17.5% |
| 2024 | 22 | 18.3% |
| 2025partial year | 20 | 16.7% |
Top 12 of 12 technology areas
Overall rank by patents
#3,132
of 49,997 tracked assignees
53.8 out of 100
What to do with this data
Guardant Health, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.